Eli Lilly & Co. Share Price

Eli Lilly & Co. Share Price

NYSE: LLY | Mega Cap
$1,440.99
+$8.61 (0.60%) Last updated on 12 Nov, 2026 | 02:33 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Eli Lilly & Co. Stock Performance

Open
$1,416.22
Prev. Close
$1,432.38
Circuit Range
N/A
Day Range
$1,415.27 - $1,440.17
Year Range
$850.64 - $1,452.66
Volume
1,05,773
Average Traded
$1,428.85

Eli Lilly & Co. Share Price Today

As of 12 November 2026, Eli Lilly & Co.'s share price is $1,440.99. The stock opened at $1,416.22, compared to its previous close of $1,432.38. During today's trading session, Eli Lilly & Co.'s share price traded between $1,415.27 and $1,440.17, with an average price of $1,427.72. Over the past 52 weeks, the stock has recorded a high of $1,452.66 and a low of $850.64. In terms of performance, Eli Lilly & Co.'s share price has risen by 30.41% over the last six months and is up 34.04% on a year-on-year basis.

Eli Lilly & Co. Share Price Chart

Line chart of the Eli Lilly & Co. price trend over the selected period. The price rose overall, ranging from 1416.02 to 1439.99, ending at 1437.79.
$1,415.27$1,440.17
L
Show Current Price
H

Eli Lilly & Co. Stock Fundamentals & Key Indicators

Market Cap
$1.29T
PE Ratio (TTM)
46.26
Dividend Yield
0.47%
EPS (TTM)
$30.96
Revenue (TTM)
$65.18B
Return On Equity (TTM)
68.49%
Profit Margin
31.67%
Debt to Equity
1.23
Quarterly Earnings Growth YoY
-2.86%

Eli Lilly & Co. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$19.29$19.80$22.97$24.40
Net Profit$6.64$7.40$7.10$6.45
Net Profit Margin34.42%37.37%30.91%26.43%
Income ChangeN/A11.45%-4.05%-9.15%

Eli Lilly & Co. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$28.54$34.12$45.04$65.18
Net Profit$6.24$5.24$10.59$20.64
Net Profit Margin21.86%15.36%23.51%31.67%
Income ChangeN/A-16.03%102.10%94.90%

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly & Co. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1,399.33
$1,437.77
+1.46%
Oct 2026
$1,149.24
$1,417.06
+21.93%
Sep 2026
$1,184.81
$1,162.17
-1.15%
Aug 2026
$1,151.54
$1,175.64
+2.33%
Jul 2026
$1,211.52
$1,148.86
-4.21%
Jun 2026
$1,096.77
$1,199.36
+8.54%
May 2026
$947.49
$1,105.00
+18.20%
Apr 2026
$930.00
$934.86
+1.65%
Mar 2026
$1,046.80
$919.73
-12.62%
Feb 2026
$1,039.78
$1,052.58
+1.43%
Jan 2026
$1,071.36
$1,037.76
-3.47%
Dec 2025
$1,073.69
$1,075.11
+0.01%

LLY Share Price FAQs